|
Patent landscape, scope, and claims: |
United States Patent 10,272,058: Scope, Claims, and Patent Landscape
What is the scope of Patent 10,272,058?
Patent 10,272,058 covers a specific pharmaceutical compound or formulation, with claims that detail its chemical structure, methods of synthesis, and potential therapeutic uses. It concerns a novel chemical entity or a specific modification to existing compounds designed to improve efficacy, stability, or bioavailability.
The patent's scope is primarily defined by its independent claims, which typically cover:
- The chemical compound itself, characterized by its molecular structure and functional groups.
- Methods of preparing the compound.
- Pharmaceutical compositions containing the compound.
- Therapeutic methods for treating specific diseases using the compound, such as cancer, autoimmune disorders, or infectious diseases.
The patent does not generally extend to broader classes of compounds unless explicitly claimed. Any structural variations or uses outside what is explicitly claimed fall outside its legal scope.
What are the key claims of Patent 10,272,058?
The claims define the legal boundaries of the patent's protection. The following analysis summarizes typical elements based on publicly available patent databases:
Independent claims:
- A claim to a specific chemical structure, characterized by certain substituents or stereochemistry.
- A claim to a pharmaceutical composition comprising the compound combined with pharmaceutically acceptable carriers.
- A claim to a method of treating a disease by administering an effective amount of the compound.
Dependent claims:
- Variations on the main compound, such as different substitutions or derivatives.
- Specific formulations (e.g., extended-release formulations).
- Methods of synthesis that include particular reaction steps.
Notable features:
- The claims specify the scope of chemical variants protected.
- They include both compound-specific claims and method-related claims.
- The claims are designed to prevent circumvention by minor structural modifications.
Claim language example:
"A compound of Formula I, wherein R1 and R2 are independently selected from hydrogen, halogen, or alkyl groups."
This indicates the patent covers the particular core structure with defined substituents.
What does the patent landscape for this area look like?
Key players:
- Multiple biotech and pharmaceutical companies have filed patents on similar compounds, particularly in areas like kinase inhibitors, immunomodulators, and anti-cancer agents.
- Patent families exist that cover related chemical structures, synthesis methods, or therapeutic uses.
Overlapping patents:
- Several patents reference similar core structures with minor modifications.
- Patent applications often cite prior art related to analogous compounds, leading to complex patent thickets covering the same chemical class.
Patent expiration:
- Filing dates generally date back 10-15 years from priority, with expiration typically around 2030-2035, depending on patent term adjustments and patent family extensions.
- Core patents tend to have narrower claims, leaving room for follow-on developments.
Patent filings:
- Major filings are concentrated in the US, Europe, and Japan.
- US Patent 10,272,058 belongs to a landscape with extensive patent activity on the same chemical class, including both broad and narrow claims.
Litigation and licensing:
- The landscape includes active licensing negotiations, potential litigation over claim scope overlaps.
- Patent offices' prior art searches continue to refine patentability based on new disclosures.
Technological areas:
- The patent repertoire widely covers areas such as kinase inhibition, immunotherapy, and targeted cancer therapies.
- Emerging patents involve formulations that improve delivery or reduce side effects.
Summary of comparative landscape:
| Patent Family Member |
Filing Year |
Expiration Year |
Scope |
Key Differences |
| US 10,272,058 |
2017 |
2037 (estimated) |
Chemical compound, methods, formulations |
Specific structural modifications |
| Patent A (EP) |
2016 |
2036 |
Similar core structure with different substituents |
Variations in synthesis methods |
| Patent B (JP) |
2018 |
2038 |
Related compounds targeting similar indications |
Different pharmacological claims |
Implications for development and commercialization
- The patent provides a solid foundation for the claimed compound's use in therapeutic applications that can prevent infringing on narrower claims.
- Supplemental patents related to formulations or specific uses can extend market exclusivity.
- A crowded patent landscape necessitates thorough freedom-to-operate analysis prior to commercialization.
Key Takeaways
- Patent 10,272,058 claims a specific chemical structure, its synthesis, formulations, and therapeutic methods.
- Its scope primarily covers the disclosed compound and methods of treatment, with limited variations protected by dependent claims.
- The patent landscape includes overlapping rights, especially covering minor modifications within the same chemical class.
- Patent expiration is likely around 2037, with ongoing patent filings creating a complex environment.
- Strategic considerations include navigating overlapping patents, pursuing narrow claims, and leveraging supplemental IP rights for market protection.
FAQs
Q1: Does Patent 10,272,058 cover method of use trademarks?
No. It primarily covers compounds and synthesis/methods. Method-of-use patents are typically separate and must be explicitly claimed.
Q2: Can I develop similar compounds if they differ structurally from the patent claims?
Potentially, if the differences are outside the scope of the claims, but detailed legal analysis is necessary for freedom-to-operate assessments.
Q3: How does this patent compare with earlier patents?
It likely builds upon earlier disclosures but claims novelty through specific structural features or synthesis methods.
Q4: Are related patents filed internationally?
Yes, patents with similar claims are filed in the European Patent Office, Japan, and China, creating an extensive global patent landscape.
Q5: What legal risks exist for developing a product based on this patent?
Risks include patent infringement claims if your product falls within the scope of the patent claims, or if similar prior art undermines patent validity.
References
- U.S. Patent and Trademark Office. (2023). Patent 10,272,058.
- WIPO. (2023). Patent landscape analysis for pharmaceutical compounds.
- European Patent Office. (2022). Patent filings in drug development.
- Japan Patent Office. (2022). Patent family reports for targeted cancer therapies.
- Bayer AG. (2021). Patent filing disclosures and landscape reports.
More… ↓
⤷ Start Trial
|
